You can buy or sell Annovis Bio and other stocks, options, and ETFs commission-free!
Annovis Bio, Inc., also called Annovis Bio, is a clinical stage drug platform company, which develops drugs to treat neurodegeneration. The firm compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndrome, and other chronic neurodegenerative disorders.
52 Week High
52 Week Low
— per share
Expected May 4, Pre-Market